ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.75
-0.08 (-1.37%)
At close: Apr 28, 2026, 4:00 PM EDT
5.64
-0.11 (-1.91%)
After-hours: Apr 28, 2026, 5:37 PM EDT
ImageneBio Employees
ImageneBio had 15 employees as of December 31, 2025. The number of employees increased by 5 or 50.00% compared to the previous year.
Employees
15
Change (1Y)
5
Growth (1Y)
50.00%
Revenue / Employee
$53,333
Profits / Employee
-$3,493,000
Market Cap
64.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15 | 5 | 50.00% |
| Dec 31, 2024 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 102 |
| OnKure Therapeutics | 45 |
| BeyondSpring | 44 |
| Cue Biopharma | 29 |
| iBio, Inc. | 20 |
| Cingulate | 14 |
| Actuate Therapeutics | 12 |
| Annovis Bio | 7 |
IMA News
- 15 days ago - ImageneBio $30 Million Private Placement Ignites Stock - Benzinga
- 15 days ago - ImageneBio Announces $30 Million Private Placement - GlobeNewsWire
- 6 weeks ago - ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update - GlobeNewsWire
- 2 months ago - ImageneBio to Participate in Leerink Global Healthcare Conference - GlobeNewsWire
- 2 months ago - ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer - GlobeNewsWire
- 5 months ago - ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team - GlobeNewsWire
- 6 months ago - ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences - GlobeNewsWire